Opportunities and challenges in China's CDC system reform: a grassroots perspective. [PDF]
Zhang Y, Zheng Y, Ye C, Li B.
europepmc +1 more source
RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research [PDF]
Rachel Thompson +18 more
openalex +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Factors Influencing Disease Perception Among Elderly Patients with Chronic Obstructive Pulmonary Disease in China: A Cross-Sectional Study. [PDF]
Li H, Liu L, Xu C, Xie J.
europepmc +1 more source
The role of iron homeostasis in remodeling immune function and regulating inflammatory disease
Qingdian Mu +6 more
openalex +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
DEDUCE: statistical inference on disease-associated genes uncovers tissue-disease associations. [PDF]
Wang B +7 more
europepmc +1 more source
Extracellular matrix: The driving force of mammalian diseases
Renato V. Iozzo, Maria A. Gubbiotti
openalex +2 more sources
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Assessing rare disease understanding: a novel disease readiness level framework. [PDF]
Kitahara K, Kano S.
europepmc +1 more source

